aRCC: 1L Treatment Options and Patient Management
Mechanisms of Resistance and Toxicity to Immune Checkpoint Therapy in Genitourinary Malignancies
By
Moffitt Cancer Center
FEATURING
Jianjun Gao
By
Moffitt Cancer Center
FEATURING
Jianjun Gao
Login to view comments.
Click here to Login
aRCC: 1L Treatment Options and Patient Management